Since 1982, Leonhardt Ventures has been a leader in developing medical devices and biologics. The company is focused on organ regeneration & recovery innovations based on the convergence of bioelectrics & biologics. Leonhardt works within Brain, Cancer, Cosmetic and Personal Care, Major Organ Regeneration, and Heart & Cardiovascular. Over 600,000 patients have been treated with Leonhardt inventions to date.
Howard Leonhardt, Executive Chairman & CEO Leonhardt Ventures
NextSense is a developer of a real-world monitoring solution to obtain insights into brain health. The company's platform collects longitudinal electroencephalogram (EEG) data from biosensing earbuds that can be worn throughout the day and night. Data collected will enable new insights and personalize treatments for neurological conditions and general mental well-being.
Docbot develops AI-based image analysis software solutions for GI care. The company's UltivisionAI Platform combines real-time computer vision, machine learning, automated reporting, and data-driven analytic tools to improve disease detection. Docbot's platform is being developed for the detection of Barrett's esophagus, esophagus cancer, stomach cancer, IBD, and colon cancer.
Luminelle is a fully integrated hysteroscopy system for in-office diagnostic and therapeutic gynecological procedures. The device has received 510(k) clearance from the US FDA for hysteroscopy and cystoscopy.
NXT Biomedical is an early stage medical device incubator working to address very large unmet clinical needs including a novel right sided cardiovascular shunt to help patients suffering from pulmonary hypertension and heart failure, as well as a wearable heart failure monitor to help improve patients QOL.
Formus Labs has developed a software-as-a-service (SaaS) solution for use in orthopedic surgeries. The company's solution is an automated 3D planner for joint replacement surgeries that combines AI and computational biomechanics to created patient-specific surgical plans. The initial software solution is focused on hip replacement surgery.
World’s first fully disposable, single-incision laparoscopic surgical device with multiple integrated technologies: stapler, grasper and dual-camera with in-line digital display for multiple common surgeries for faster surgery, quick recovery from single small hole and shorter anesthesia. StaplCam will revolutionize ASC, Small, Medium and Rural Hospitals. Additionally, the multi-generation product is for general surgery, women's health and thoracic surgery.
Dinesh Vyas, CEO StaplCam
True Vision Treatment (TVT) is Yolia Health's two step therapeutic process for the treatment of vision problems like presbyopia and myopia. The TVT solution consists of creating personalized contact lenses using corneal eccentricity & topography & TVT eye drops to increase corneal maleability to correct near and distant vision without surgery.
IOPtic is developing a permanently implanted sensor to measure intraocular pressure in patients with glaucoma.
Alan Crunkleton, President & CEO IOPtic
MY01 has developed a device to continuously monitor and manage acute compartment syndrome in muscles. The MY01 device is a sterile, single-use device that quickly measures muscle pressure following orthopedic surgery for trauma.
Cava Health is developing a smart, health tracking solution to monitor gut health, track body composition, and monitor vitals. The company's Cava Seat captures these health metrics through a "smart" toilet seat.
Developing the first bioabsorbable, flow-diverting stent for the treatment of brain aneurysms. The device is being designed to self-expand and be highly flexible for use in the delicate blood vessels of the brain.
Nano4Imaging has developed an magnetic resonance (MR) compatible guidewire to transfer select cardiovascular procedures from the cathlab to the MRI suite. Initially focused on developing their solutions for congenital heart diseases, the company plans to expand their technology into interventional procedures, such as angioplasty.
Synapse Dental is the developer of the Dental Pain Eraser, a pen-shaped solution that prevents and alleviates oral pain, drug-free and within seconds of application for the dental office and home-use. It uses patented Pulse Wave technology that delivers subsensory electrical stimulus to disrupt the sensation of pain derived from dental procedures and oral disorders. It temporarily alters the mechanism of the biological pain cascade without numbness.
PhotoPharmics is developing a phototherapy device for the treatment of neurodegenerative disorders. The company's technology delivers specialized wavelengths of light through the eyes to treat neurodegenerative and neuropsychiatric disorders. PhotoPharmics is initially developing its technology for the treatment of Parkinson's disease.
Otolith is developing a wearable device for the treatment of vertigo. The device delivers a precise level of mechanical stimulation to the acceleration sensors of the inner ear. The therapeutic vibration masks vertiginous signals from the vestibular system to alleviate vertigo symptoms.
Vitara is developing a therapeutic platform to support infants born premature. It is the company's mission to protect preterm infants, improve their quality of life, and reduce comorbidities and mortality.
Caretaker is a comprehensive vital sign monitoring platform designed to connect clinicians to their patients, whether the patient is in hospital mobile or at home. The Caretaker solution allows clinicians to continuously monitor all core vital signs with ICU-level accuracy, using a wearable and non-invasive package.
SpinTech MRI is dedicated to addressing clinical and operational challenges in magnetic resonance imaging. The company's STAGE (strategically acquired gradient echo) solution reduces MRI acquisition and processing time, improving patient throughput and workflow efficiency. The solution integrates with virtually all MRI systems and manufacturers.
Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software.
Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hi replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants.
Total Flow Medical is developing solutions to improve outcomes during patients undergoing heart surgery. The company's initial product is an easy-to-use cannula for use during minimally invasive cardiopulmonary bypass surgery. The device is being designed to improve the current clinical wokflow and patient quality of life.
Hillary Pierce, CEO Total Flow Medical
Innovator Spotlight Digital Presenter
CrossBay Medical is dedicated to developing medtech solutions for women's health based on the company's CrossGlide Technology. The company's unique technology enables frictionless crossing during uterine access procedures, including endometrial biopsy, cervical dilation, and embryo transfer for in-vitro fertilization.
Lineus Medical has developed SafeBreak, a device that preserves life of the IV line that would otherwise be replaced after removal. SafeBreak stops the flow of fluids and creates dual occlusions. The device compliments current hospital equipment, and impacts infections, patient satisfaction, nurse stress, and length of stay.
Noninvasix is using optoacoustic technology to monitor critically ill patients in the hospital. The company is developing a non-invasive device monitor patients for sepsis and septic shock in real-time. The device will enable healthcare providers to rapidly diagnose, monitor, and respond to these life-threatening conditions in patients.
Telesair is developing a respiratory support system for use in the home. The company's solution is intended to reduce the time patients spend in the hospital, without reducing the quality of care they receive upon being discharged.
206 Ortho has developed and patented a unique bioresorbable, high strength material to repair broken bones. The company's solution is an alternative to metal implants, improving patient care, quality of life and eliminate the costs associated with elective surgeries to remove implants.
The company's NIO Laser Imaging system uses Stimulated Raman Histology to image unprocessed tissue specimen without requiring sample preparation to enable histological evaluation of tissue outside of a laboratory.
Jay Trautman, Co-Founder & Director Invenio Imaging
Innovator Spotlight Digital Presenter
Renovos Biologics is an innovative startup focused on developing regenerative medicine technologies utilizing the company's proprietary synthetic nanoclay gel, Renovite. Renovite functions as an injectable scaffold that creates a localized environment that is conductive to regenerative cells and retains the delivered biologics at low doses that do not inhibit effectiveness.
Vascular access device that provides reliable, repeatable access with fewer complications, by allowing physicians to maintain access in an occluded vein and eliminate the need to compromise an additional vein.
Gabriele Niederauer, CEO Bluegrass Vascular Technologies
Developing solutions to simplify critical care in neurocritical patients. BrainSpace is committed to improving the way brain pressure is managed in patients recovering from stroke, traumatic brain injury, and neurosurgery.
Wearable patch that utilizes ultrasound to continuously monitor cardiac output and performance. The Pulsify Patch is intended to offer new insights into patients' cardiovascular health that can't be captured using traditional catheter and ultrasound transducer-based approaches.
MediView is innovating healthcare delivery with a digital surgery solution that harnesses augmented reality (AR) to unlock new insights during ultrasound-based procedures, as well as during procedures in the operating room. The company's solutions enable providers to colloborate, navigate, and enhance visual capabilities.
The company has developed iotaSoft, a miniature robotic system that is the size of a thumb. iotaSoft is capable of more accurately guiding the electrode of the cochlear implant through the ear, without damaging sensitive areas of the ear. The added precision that comes with the robotic platform is intended to reduce the incidence of reported hearing loss that can occur when cochlear implants are inserted manually.
Molecular breast imaging (MBI) technology to more accurately diagnose early-stage breast cancer in women with dense breast tissue. The Eve Clear Scan platform utilizes gamma cameras and intravenously injected cancer tracers to identify rapidly growing cancer cells that can potentially evade detection with traditional mammogram technology.
PrecisionOS develops software solutions that leverage extended reality to enhance surgical performance while accelerating the safe use of medical devices. The solutions are part of the digital surgery ecosystem helping to improve surgical outcomes through enhanced experiential pre-operative planning and training.
Sanket Chauhan, Founder & CEO Surgical Automations
INDIUS Medical Solutions Inc. is a spinal medical technology company developing end-to-end solutions from an AI based Diagnostics & Surgical Planning software platform to Innovative Spinal Implants for the treatment of Complex Spinal Disorders across the world. Armed with 5 US FDA approvals (full spine portfolio in pipeline), 11+ patents (US, INDIA, EU & Japan) and 1400+ patients successfully treated worldwide, INDIUS' Mission is to reduce the 30% post-operative complications rate in Pediatric Spinal Scoliosis Surgery through the Power of Data and Patient Specific Self-Actuating Growth based Implant Systems.
Aditya Ingalhalikar, PhD, Founder & CEO INDIUS Medical Solutions
Endoluxe is a world-class wireless endoscopic video imaging organization launching its industry design award-winning Endoluxe EVS Orb. The company is focused on reducing costs of legacy video platforms, enhancing procedure adoption, and improving patient outcomes through better therapy application utilizing advanced AI/ML functionality. Endoluxe is positioned to disrupt the market as a vendor agnostic platform that allows clinicians to utilize their existing investment in traditional scopes and supporting devices, utilizing a portable, integrated, and feature-rich platform at 1/10th the cost of legacy products. More information can be found at Endoluxe.com.
Limax has developed HEMOMax, a multifaceted solution to augment vascular reconstruction and wound management. The company's fully degradable hydrogel-based material has strong adhesion to difficult to attach surfaces like the surface of a bloody and beating pig heart, highlighting its unprecedented strong and flexible adhesion. The biomaterial can withstand high pressures and serve as a hemostatic agent in advanced bleeding scenarios.
Benjamin Freedman, PhD, President & CEO Limax Biosciences
Facible Biodiagnostics is leading the diagnostic testing revolution through our mission to provide hospital-grade diagnostic tests to everyone, everywhere. Our patented Q-LAAD technology allows us to develop diagnostics tests without the tradeoff between speed, accuracy, and ease of use inherent in legacy diagnostic testing technologies. Join us to learn more about the diagnostic testing revolution.
FDA Cleared heat therapy system for the temporary relief of minor muscle and joint pain and stiffness of the hand. The AVACEN system is a non-invasive therapeutic device that uses heat to improve microcirculation, enhancing the delivery of nutrients and oxygen through the circulatory system.
NovaResp is developing technology to improve the prediction of respiratory events in patients using positive airway pressure (PAP) machines. The company's platform uses artificial intelligence and machine learning to monitor respiration and prevent detrimental episodes of apnea.
Hamed Hanafi, President & Director of R&D NovaResp Technologies
Kurve brings a breakthrough approach to treat CNS disorders like Mild Cognitive Impairment, Alzheimer's, and Parkinson's. Kurve has completed Phases I, II, IIB and is Phase III ready in MCI. Kurve successfully delivers our proprietary medications through the blood brain barrier with a next generation drug delivery technology. Kurve brings revolutionary new treatments for CNS disorders through technology and drugs that modify the disease, creating breakthrough successes in medication effectiveness and quality of life. With demonstrated clinical efficacy, Kurve is changing the landscape of CNS therapies.
Entvantage Dx is an in-vitro diagnostic company dedicated to reducing antibiotics for ENT illnesses. The company's lead product, Sinu-Test Diagnostic Kit qualitatively identifies the three pathogenic bacteria at the point-of-care that commonly cause bacterial sinusitis - enabling physicians to determine which patients require antibiotics for treatment.
Joseph Skraba, President & CEO Entvantage Diagnostics
Heart Repair Technologies is developing minimally invasive transcatheter technology for the repair of functional mitral and tricuspid valve disease in mitigating severe mitral and tricuspid valve regurgitation.
Pulse Infoframe has developed a robust platform for accelerating evidence generation and collaborative research through quality real-world data (“RWD”) at scale. The platform fulfills regulatory requirements and reduces time-to-market for new products. The company's healthie™ 2.0 platform (“H20”) is hyper-scalable and purpose-built to enable real-world evidence (“RWE”) and innovative trial design.
Dr. Femida Gwadry-Sridhar, Founder & CEO Pulse Infoframe
TibaRay is developing a next-generation radiation therapy technology, called PHASER, to deliver radiation treatment with unprecedented accuracy and exquisite shaping by ultrafast imaging. The PHASER system verifies tumor and organ positioning and "freezes" motion as treatment is delivered.
Lucid is developing solutions to help clinicians diagnose and manage the progression of esophageal disease. The company has developed to solutions that allow clinicians to effortlessly collect and analyze esophageal cells to identify Barrett's Esophagus.
Lishan Aklog, MD, Chairman & CEO Lucid Diagnostics
Exciton Pharma Corp (EPC) is a late-stage pre-clinical, multi-asset biotech company developing first-in-class compounds for the inclusive treatment of infection and skin diseases. With a singular therapeutic approach to infection, inflammation, and healing, EPC is transforming the way to approach infectious disease. Disrupting convention to empower patients to regain control over their own unmet needs.
Wearable Artificial Organs is developing truly portable solutions for use in patients with End Stage Renal Disease (ESRD). The company has currently prototyped two wearable device, a cordless continuous renal replacement therapy (CRRT) system and a wearable artificial kidney.
11 Health's Virtual HealthCare Ecosystem is a comprehensive platform for managing chronic digestive conditions. The platform connects patients, healthcare providers, and insurance companies through its SmartCare App. The platform integrates wearable devices, remote patient monitoring data, clinical services (e.g. teleconsultations), and educational resources to support patients throughout their health journey.
Proprio is using multi-camera imaging to create digital representations of the surgical field through augmented reality and machine learning. The company is developing the PARADIGM system, a digital surgery platform to provide surgeon with new insights during surgery. PARADIGM will give surgeons real-time surgical insights through a headset that offers them pre-operative imaging data, virtual annotation, collaborative feedback, and digital magnification within their field-of-view.
Poseydon Medical's Oryon is a unique aspiration catheter system for the treatment of acute ischemic stroke. The device is being developed with feedback by interventionalists to create the "ideal" device. The key design feature of Oryon is its "super bore" design, which allows the device to completely envelop blood clots.
Nyra Medical is developing an image-guided, catheter-based intervention, called the cardiac leaflet enhancer (CARLEN), for the treatment of mitral and/or tricuspid regurgitation in heart failure patients.
Rapid Nexus has developed a first of its kind nanotechnology wound dressing, along with devices that accelerate healing, to rapidly close chronic non-healing wounds. The wound management platform consists of a nanotechnology wound gel dressing formulation (HemastylRx) and Gen-Ray, a device to apply mild-heating to the wound to accelerate absorption and stimulate the healing process.
Altoida is using technology to predict the onset of neurlogical diseases, such as Alzheimer's disease, before symptoms occur. The company's platform evaluates an individual's risk by interrogating 800 digital biomarkers collected through a digital assessment and augmented reality (AR). A proprietary artificial intelligence (AI) algorithm analyzes these findings to assess brain health and predict neurological disease development.
IRegained's MyHand system is a neuro-rehabilitation device to restore motor control to the hand in patients who have sustained brain injury due to stroke, accident, or TBI. The platform stimulates neuroplasticity in the mind and restores motor function through a combination of intelligent algorithms to personalize therapy, interactive exercises, hand training protocols, and telemedicine.
Materna Medical is developing solutions to improve pelvic health in women. The company's first product, Milli, is designed to addressed pelvic pain in the general population. Materna is currently developing a second product designed to expedite labor and reduce pelvic damage during the initial stage of labor.
Sense Biodetection develops and commercializes an easy-to-use, affordable, disposable molecular diagnostic testing platform. The company's products are portable and quickly obtain PCR-based results to truly bring diagnostic testing to the point-of-care.
OYE (Open Your Eyes) Therapeutic's intervention is set to remove over $5.5B in annual avoidable costs from US hospitals and surgery centers by solving the defined problem of delayed operating room turnover due to extended emergence time from anesthesia.
PECA Labs is a commercial-stage developer of polymeric heart valves and vascular grafts. We have already received FDA and CE Mark clearance for a novel vascular graft capable of providing growth potential. Within the next 18 months we further expect to receive FDA marketing clearance the first fully-polymeric pulmonary valve and a best-in-class anti-thrombogenic vascular graft, as well as receive FDA IDE clearance for our polymeric transcatheter aortic valve. Our highly differentiated product suite addresses a >$9B US market and is covered by multiple patents that will not expire until the mid-2030s. We will be raising a Series B in mid-2023 to support the further commercialization and growth of these product lines.
Synova Life Sciencesis a biotechnology company that has developed a proprietary methodology and system for processing fat cells into autologous stem cells. Using Synova's approach, clinicians and researchers are able to obtain greater yields of stem cells 30 times faster than the current gold standard for stem cell harvesting.
NeoPredix is utilizing digital health solutions and intelligent algorithms to support maternal, neonatal, and perinatal care. The company's prediction software will support clinical decision makers, allowing them to personalize and optimize patient care based on deep medical data and science.
Organ transplantation involves many challenges. One of these challenges involves preservation of the limited supply of healthy donor organs. To address this, New York Huaqi Bioengineering is developing products to preserve and enhance the health and functionality of donated human organs.
Carevature Medical develops advanced orthopedic solutions to address limitations of current surgical solutions. The company's flagship product, Dreal, is a cutting device with a curved design that improves access and reduces trauma in spinal surgeries.
Tada Medical's ReLink Care is a CE-marked breakaway connector for intravenous (IV) lines. The device is designed to reduce complications and costs due to accidental disconnections that occur during home and hospital infusion therapy.
NELA BioDynamics develops next-generation orthopedic implants. The company develops modular implants that adapt and improve load transmissions in the implant areas. Customizable orthopedic implants have been shown to reduce intervention time and costs and improve recovery time post-surgery.
True Digital Surgery develops next-generation solutions for the operating room. The company's flagship system, Occipta, is a heads-up, digital mircoscope and imaging platform intended to improve surgeons' control and visualization capabilities during reconstructive surgery.
September Riharb, VP of Corporate Development True Digital Surgery
Mindera's SkinAtlas is a scalable platform that leverages artificial intelligence and machine learning to analyze patient-specific data collected from a dermal biomarker patch. Analysis of genetic biomarkers, particularly those derived from RNA, will help healthcare providers more effectively diagnose and determine the appropriate therapeutic for the treatment of psoriasis.
Moray Medical is harnessing robotics to democratize edge-to-edge mitral valve repair. The company's initial product is the Coral system, which will combine augmented reality (AR) visualization, a digital user interface, and microfluidics to simplify mitral valve repair procedures.
Supporting the development of wearable microsensors for the measuresment of biometric signals. LifeSignals works with companies to develop health and wellness monitoring solutions with their portfolio of patented hardware and software.
Zeto's electroencephalogram (EEG) is an FDA-cleared alternative to traditional EEG setups. The company has developed a wearable headset that is wireless, eliminates the need for preparation (e.g. gel application), and fully integrates with cloud data systems for real-time data viewing and management.
SIVA Therapeutics mission is to develop minimally invasive devices for cancer treatment. To achieve this goal, the company is developing a nanotechnology platform that utilizes targeted hyperthemia to heat and destroy solid tumors and spare healthy tissues.
A predictive health company developing the next generation of medical devices with smart sensors and artificial intelligence. The company's Accuryn system transforms a Foley catheter into a real-time sensor of urine output, intra-abdominal pressure, and core body temperature to monitor risk of acute kidney injury.
CytoVeris is harnessing precise, smart cancer imaging solutions, by converging advanced optical imaging technologies and artificial intelligence to bring new, real-time, intraoperative cancer visualization capabilities to the operating room in order to improve the quality of cancer resections, enhance patient outcomes and reduce economic burden across the healthcare continuum.
Improving the quality of care for Structural Heart Disease patients by providing innovative personalized simulations for informed pre-op preparation toward a better quality of life for people with heart disease.
PreciPoint develops hardware and software solutions for digital microscopy. The company is an end-to-end provider for digital microscopy, from image generation, image analysis, and microscopic databases for data storage.
Berkshire Biomedical Corporation is developing drug delivery devices by pioneering the use of biometric technologies, combined with cloud-based and physician-enabled remote management systems to provide accurate personalized medication delivery to the authenticated Intended User. The Company’s lead product under development, the Computerized Oral Prescription Administration (COPATM) System, is an authenticated Intended User automated oral liquid dispensing system designed to deliver controlled and non-controlled liquid oral medications to only the Intended User upon confirmation of fingerprint and dentition biometric identification.
Wearable technology designed to treat the root cause of female incontinence. The Innovo device engages the pelvic floor muscles via 30 minute sessions that have been clinically proven to reduce and eliminate leaks due to stress urinary incontinence.
Day Zero Diagnostics uses whole genome sequencing and machine learning to modernize infectious disease diagnosis and treatment. DZD is developing a rapid diagnostic for sepsis that uses genomic data to identify a pathogen and to comprehensively profile its antibiotic resistance, as well as services for hospital infection control. Our goal is modernize hospital microbiology using NGS and a big-data approach.
Surgeon-invented T-Line® Hernia Mesh with integral suture-like extensions designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength. Additional products in development include an anchor clip for even faster, easier implantation; a biosynthetic version of the T-Line Hernia Mesh; and a coated composite version of the T-Line Mesh.
Operating at the Intersection of Machine Vision and Digital Surgery, we aim to take the guesswork out of 23+ Million hospital-based procedures. Advanced Scanners is developing a real-time surgical navigation system that will enable the shift to fully-automatic robotic surgical procedures.
Improving lives by healing wounds and saving limbs, Vaporox was formed to commercialize Vaporous HyperoxiaTherapy(VHT™). VHT is a patented and FDA-510K-cleared technology that represents a breakthrough in treating 7 different types of skin wounds, including diabetic foot ulcers (DFUs) and pressure ulcers (bedsores).
Minimally invasive medical devices for peripheral vascular and neurovascular. The company's products utilize a shape-memory, biocompatible polymer to achieve better vessel occlusion with fewer devices per procedure than existing metal implants.
Patheous Integrated Dysphagia Care (iDC) helps seniors and senior care providers diagnose and treat the dysphagia episode of care through the coordinated use of our patented remote patient monitoring technology, mobile imaging diagnostics, evidence-base therapeutic applications and nutrition coaching applications.
Retia makes advanced hemodynamic monitors using the patented Multi-Beat Analysis MBA™ algorithm to guide care for high-risk surgical and ICU patients. Using the data from our monitor, clinicians implement proven protocols that reduce acute kidney injuries, myocardial injuries and other costly complications.
Anavasi Diagnostics is a molecular diagnostic company using miniaturized RT-LAMP technology to provide lab-quality molecular diagnostic results in the CLIA-waived / POC environment, and eventually, the home -- in 30 minutes, on average.
Nelson Patterson, CEO Anavasi Diagnostics
PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment.
The OtoSight Middle Ear Scope enables clinicians to quickly and easily see directly through the eardrum to directly visualize the middle ear, drastically improving care for middle ear infections, the leading cause of hearing loss, antibiotic use, and surgeries in children. The novel device has new reimbursement codes that are seeing robust payment rates.
Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits. The devices utilize a low-cost image processing unit which also serves as a portal to cloud-based software supporting the entire surgical episode.
Sense is developing a non-invasive, wearable device that continuously monitors brain activity primarily in the intensive care unit. The device uses low power radiofrequency pulses to classify stroke and traumatic brain injury by subtype.
New procedure to mimic the clinical effects of tibial osteotomy procedures. Implants will be delivered to the proximal tibia below the patellar tendon, offloading and re-directing the tendon to reduce pain and inflammation.
AiM Medical Robotics is developing a portable MRI compatible surgical robot for use in the OP and MRI suite. The system is being designed for the treatment of functional brain disorders (e.g. epilepsy, Parkinson's disease).
Focused on eliminating pre and post-operative bacterial infections. Sonix-A8 technology kills bacteria on and below the surface of skin where traditional treatments cannot reach. A non-pharmaceutical, non-chemical, and non-UV light-based device to kill any all bacteria (Gram-negative or Gram-positive) including Superbugs like MRSA without giving rise to Antimicrobial Resistance (AMR) bugs.
Micro Interventional Devices, Inc. (MID) is a development stage medical device company focusing on the design, manufacture and commercialization of disruptive technologies for use in percutaneous structural heart repair procedures.
A Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.
Vena Vitals is an early stage med-tech company focused on non-invasive continuous blood pressure monitoring. The company's proprietary technology is a soft flexible sensor that conforms to the skin for direct pressure measurement at theradial artery. The company's technology is intended to replace unnecessarily invasive arterial line measurements as well as non-continuous cuff-based methods in both the hospital and at home.
HealthySole is the pioneer and technology leader in reducing the pathogen load in settings where pristine environments are required: hospitals, compounding pharmacies, pharmaceutical R&D and manufacturing, food handling, and even EMS and law enforcement.
Alio's SmartPatch is a discrete patch that continuously monitors and tracks vitals, including O2 saturation, temperature, blood pressure, and more. The company's remote patient monitoring platform is being developed as an alternative to one-metric devices and consumer-grade sensors (i.e. fitness trackers) that do not capture clinical-grade data.
Dymicron is an innovation-driven medical technology company that is advancing a new generation of musculoskeletal devices made from Polycrystalline Diamond (PCD)—one of the strongest substances known to man, and a material for which Dymicron has exclusive patented use in all human interbody applications.
Long-term, non-thermal resolution of atrial fibrillation. AtriAN Medical is developing an innovative solution for the treatment of AF that utilizes micro-Pulsed Electric Field (mPEF). This non-thermal approach targets hyperactive cell structures on the outside of the heart and disrupts the errent electrical signals that are responsible for AF, while sparing healthy tissue.
Digital-Surgery-as-a-Service (DSaaS) combining the power of a new microsurgery platform with a system of big data analytics and machine learning to provide advanced surgical assistance in performing delicate or intricate procedures.
CorInnova is developing a minimally invasive, soft robotic cardiac device for the short-term treatment of acute heart failure. The device gently conforms to the heart's surface, applying compressions to increase cardiac output without contacting the blood - eliminating a major risk of thrombosis and stroke.
e-Scopics is democratizing ultrasound imaging for all healthcare professionals. The company manufactures a digital transducer and a connected software APP to provides quantitative imaging for several medical conditions. The image formation process is no longer hardware based but rather a SaaS running on a cell phone, a Tablet or the Cloud, with AI based algorithms for quantitative diagnosis.
Manny Villafaña, PhD, Sc, Founder of St. Jude Medical, ATS, Cardiac Pacemakers Medical 21
In-Person Presenter Innovator Spotlight
Unintended retained foreign object (URFO) is the #1 "never-event" in hospitals. Melzi Sharps Finder helps surgeons inspect the surgical area for metal objects during open, laparoscopic, and robotic surgeries.
Nanochon is applying novel materials to replicate bone and cartilage, and high-end 3D printing to create an implant which can permanently repair debilitating joint injuries. The implant can bear loads like a traditional joint implant, quickly restoring a patient’s movement.
Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical hardware to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement.
New View Surgical, Inc. is an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery. The VISIONPORT™ platform is a novel surgical visualization and access system that aims to simplify and cost-reduce the technology required to perform minimally invasive abdominal and thoracic procedures. The company's mission is to increase access to minimally invasive techniques for patients around the world.
Bionic vision for those who have lost their sight. Bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling them to regain partial visual perception and greater autonomy.
Developing and commercializing the Phagenyx platform, which consists of a treatment catheter and base station. Introduced through the nose, the Phagenyx catheter delivers electrical stimulation to the throat to treat dysphagia (difficulty swallowing).
Joseph McGinley, Founder & CEO McGinley Orthopedics
In-Person Presenter Innovator Spotlight
FluidIQ is developing solutions based on its proprietary fluidics technology. The company's first solution, HOPE InVent, is a low-cost, rapidly manufacturable (via 3D printing), deployable ventilator that can be used in areas of need where ventilators are scarce, unavailable, or are impractical (because of resource deplete and harsh environments or due to limited supplies of standard ventilators).
GLW is an innovation-driven, commercial-stage, orthopedic technology company focused on investing in and developing orthopedic implants. The company is currently invested in three commercial-stage portfolio companies that develop and commercialize innovative orthopedic solutions.
Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications.
Dave Blue, Chief Commercial Officer Shoulder Innovations
Early Detection is focused on detecting cancer at its earliest stages - while the tissue is still considered precancerous. Early Detection has developed a test to detect an altered sugar associated only with precanceous and cancerous tissue. The test can be delivered at the point-of-care and provides in-office results for patients and providers.
Transforming the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.
Developing the Future of Tendon and Ligament Healing
Biorez is a medical device company committed to helping patients return to full activity sooner and safer following debilitating ligament and tendon injuries. We developed the BioBrace™ implant, the first FDA-cleared bio-inductive soft-tissue scaffold that was specifically designed and is indicated to mechanically reinforce tendons and ligaments while promoting tissue regeneration and healing. Since May of 2021, we have been selling to hospital systems and surgery centers in a limited commercial launch phase. To date, surgeons have successfully used the BioBrace in rotator cuff repairs, ACL reconstructions, Achilles’ tendon repairs, total shoulder replacements, and many other orthopedic procedures. Biorez is raising $15M in Q2 2022 to accelerate our commercial growth by building our sales channel and executing post-market clinical work to validate our best-in-class technology platform.
The Osso VR team has developed an orthopedic surgical training platform that allows surgeons to go "hands on" in an immersive, virtual training environment. The surgical simulation technology allows healthcare providers to participate in guided lessions, practice procedures and test new technologies, and analyze training data.
Designer and manufacturer of medical simulation products. Core range of simulators includes ‘take-home’ laparoscopic simulators and a range of institutional based laparoscopic simulators. The company offers a growing range of simulators for teaching skills in critical care, medicine hysteroscopic and general surgery.